PSMC2 and breast carcinoma: Both mRNA and protein levels of PSMC2, PSMC3, PSMC4, PSMC5, and PSMC6 were significant in cancer tissues, and PSMC1, PSMC3, PSMC4, PSMC5, and PSMC6 overexpression was associated with poor prognoses of breast cancer patients.